These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5292099)

  • 1. Effect of nimergoline (F.I. 6714) on human platelet aggregation in vitro.
    Praga C; Pogliani E
    Acta Med Scand Suppl; 1971; 525():263-6. PubMed ID: 5292099
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of the inhibitory effect of some antiaggregating drugs in " vitro".
    Polli EE; Praga C; Cortellaro M; Pogliani E
    Acta Univ Carol Med Monogr; 1972; 53():199-210. PubMed ID: 4670728
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of the function of human blood platelets in vitro by VK 744.
    Sixma JJ; Trieschnigg AM
    Acta Med Scand Suppl; 1971; 525():237. PubMed ID: 5292096
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vitro and in vivo effect of xanthinol niacinate on platelet aggregation, adhesion and blood coagulation.
    Balkuv S; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(4):179-87. PubMed ID: 5609339
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemostatic abnormalities in heroin addicts.
    Puszkin E; Gutfreund D; Aledort LM
    Transfusion; 1972; 12(1):9-11. PubMed ID: 5009587
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aminophylline on blood platelet reactions.
    Brinson K
    Atherosclerosis; 1972; 16(2):233-9. PubMed ID: 4404505
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clonixin and aspirin on platelet aggregation in human volunteers.
    Arkel YS; Schrogie JJ; Williams R
    J Clin Pharmacol; 1976 Jan; 16(1):30-3. PubMed ID: 1245606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].
    Le Menn R; Migne J; Prost-Dvojakovic RJ
    Therapie; 1977; 32(2):205-14. PubMed ID: 898128
    [No Abstract]   [Full Text] [Related]  

  • 10. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of a new analgetic-antiphlogistic compound (2-(2-methyl-3'chloro)-anilino-nicotinic acid) on platelet function and fibrinolytic activity in vitro.
    Widmer K; Reed RC; Friereich EJ; Freireich EJ
    Thromb Res; 1975 Jan; 6(1):9-17. PubMed ID: 1118832
    [No Abstract]   [Full Text] [Related]  

  • 12. Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregation.
    Tilford CH; MacKenzie RD; Blohm TR; Grisar JM
    J Med Chem; 1973 Jun; 16(6):688-93. PubMed ID: 4715003
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ADP-induced platelet aggregation by furosemide.
    Rossi EC; Levin NW
    J Lab Clin Med; 1973 Jan; 81(1):140-7. PubMed ID: 4682187
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lysergide and nimergoline on glucose metabolism investigated on the dog brain isolated in situ.
    Benzi G; De Bernardi M; Manzo L; Ferrara A; Panceri P; Arrigoni E; Berté F
    J Pharm Sci; 1972 Mar; 61(3):348-52. PubMed ID: 5013366
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of xanthinol niacinate on ADPand adrenaline-induced platelet aggregation.
    Svehla C; Rysánek K; König J; Spánková H; Mlejnková M
    J Pharm Pharmacol; 1968 Feb; 20(2):153. PubMed ID: 4384542
    [No Abstract]   [Full Text] [Related]  

  • 16. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB
    Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of cyclic AMP levels and aggregation in human platelets by prostaglandin E .
    McDonald JW; Stuart RK
    J Lab Clin Med; 1973 Jun; 81(6):838-49. PubMed ID: 4351012
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of platelet aggregation by anti-5-hydroxytryptaminic and alpha-adrenergic blocking agents.
    Fregnan GB
    Acta Univ Carol Med Monogr; 1972; 53():263-8. PubMed ID: 4151573
    [No Abstract]   [Full Text] [Related]  

  • 20. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.